877 related articles for article (PubMed ID: 7657807)
21. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
Hui W; Bell MC; Carroll GJ; Layton MJ
Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
[TBL] [Abstract][Full Text] [Related]
22. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
Terada S; Suzuki E; Ueda H; Makishima F
Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
[TBL] [Abstract][Full Text] [Related]
23. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
[TBL] [Abstract][Full Text] [Related]
24. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Amaral MC; Miles S; Kumar G; Nel AE
J Clin Invest; 1993 Aug; 92(2):848-57. PubMed ID: 7688764
[TBL] [Abstract][Full Text] [Related]
27. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
28. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
29. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
30. Interactions between oncostatin M and the IL-6 signal transducer, gp130.
Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M
Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.
Gu ZJ; Costes V; Lu ZY; Zhang XG; Pitard V; Moreau JF; Bataille R; Wijdenes J; Rossi JF; Klein B
Blood; 1996 Nov; 88(10):3972-86. PubMed ID: 8916964
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
[TBL] [Abstract][Full Text] [Related]
33. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
Ichihara M; Hara T; Kim H; Murate T; Miyajima A
Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
[TBL] [Abstract][Full Text] [Related]
34. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
35. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
Modrell B; Liu J; Miller H; Shoyab M
Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
[TBL] [Abstract][Full Text] [Related]
36. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone.
Malaval L; Gupta AK; Liu F; Delmas PD; Aubin JE
J Bone Miner Res; 1998 Feb; 13(2):175-84. PubMed ID: 9495510
[TBL] [Abstract][Full Text] [Related]
37. Oncostatin M: a new potent inhibitor of iodine metabolism inhibits thyroid peroxidase gene expression but not DNA synthesis in porcine thyroid cells in culture.
Isozaki O; Tsushima T; Miyakawa M; Emoto N; Demura H; Arai M; Sato-Nozoe Y
Thyroid; 1997 Feb; 7(1):71-7. PubMed ID: 9086575
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
39. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]